COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients

Nov 5, 2020 | IOIBD papers (task forces), News

Special Issue JCC Journal on Covid-19 and IBD – a collaborative work of IOIBD and ECCO. https://academic.oup.com/ecco-jcc/issue/14/Supplement_3 Providing guidance during a global viral pandemic for the care of patients with Inflammatory Bowel Disease Supplement...

Role of biomarkers in the study and management of inflammatory bowel disease: a “non systematic” review

May 11, 2012 | IOIBD papers (task forces)

Role of biomarkers in the study and management of inflammatory bowel disease: a “non systematic” review https://www-ncbi-nlm-nih-gov.eresources.mssm.edu/pubmed/25222663 Sachar DB; Biomarkers Task Force of the IOIBD. Inflamm Bowel Dis. 2014 Dec;20(12):2511-8. Bernstein...

Geographic variability of environmental risk factors in inflammatory bowel disease.

May 11, 2011 | IOIBD papers (task forces)

Gut. 2013 Apr; 62(4):630-49. Bernstein CN, Ng SC, Lakatos PL, Moum B, Loftus EV Jr, Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD).

Hospitalisations and surgery in Crohn’s disease. 

May 11, 2011 | IOIBD papers (task forces)

Gut. 2012 Apr; 61(4):622-9. Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV Jr, Tysk C, O’Morain C, Moum B, Colombel JF , Epidemiology and Natural History Task Force of the International Organization for the Study of Inflammatory Bowel Disease...